Experienced investor and operating executive focused on growth-stage technology and healthcare companies, with expertise in corporate strategy, capital raising and operational scaling. Carrie Miller brings cross-functional experience from senior roles in private equity and venture-backed startups, advising boards on go-to-market and M&A. Active in sourcing early growth opportunities, structuring rounds and supporting management teams on commercialization and financial governance. Regular commentator in investor forums and known for pragmatic, growth-oriented value creation.
Experienced investor and operating executive focused on growth-stage technology and healthcare companies, with expertise in corporate strategy, capital raising and operational scaling. Carrie Miller brings cross-functional experience from senior roles in private equity and venture-backed startups, advising boards on go-to-market and M&A. Active in sourcing early growth opportunities, structuring rounds and supporting management teams on commercialization and financial governance. Regular commentator in investor forums and known for pragmatic, growth-oriented value creation.
Prioritizes growth-stage technology and healthcare investments where operational leverage and repeatable go-to-market can accelerate scale. Emphasizes rigorous commercial due diligence, disciplined capital allocation across tranche-based rounds, and active board-level partnership to drive revenue, margin expansion and M&A optionality. Balances conviction bets with portfolio diversification, favors companies with defensible distribution channels and strong metrics, and deploys pragmatic governance and milestone-driven capital to de-risk execution.
Prioritizes growth-stage technology and healthcare investments where operational leverage and repeatable go-to-market can accelerate scale. Emphasizes rigorous commercial due diligence, disciplined capital allocation across tranche-based rounds, and active board-level partnership to drive revenue, margin expansion and M&A optionality. Balances conviction bets with portfolio diversification, favors companies with defensible distribution channels and strong metrics, and deploys pragmatic governance and milestone-driven capital to de-risk execution.
| Trades 362 | Longs Won 304/362 83% | Profit Factor 192.41 |
| Profitability | Shorts Won 0/0 0% | Standard Deviation $1.48M |
| Average Win $368,075.19 | Best Trade (Jul 16) $15.95M | Sharpe Ratio -74.72 |
| Average Loss -$10,026.59 | Worst Trade (Jul 16) -$59,659.51 | Z-Score 19.03 (100%) |
| Commissions $0 | Avg. Trade Length 1y 7m 2w 1d | Expectancy $307,495.35 |
| Loss Size | 100% | 90% | 80% | 70% | 60% | 50% | 40% | 30% | 20% | 10% |
| Probability of Loss | <0.01% | <0.01% | <0.01% | <0.01% | <0.01% | <0.01% | <0.01% | <0.01% | <0.01% | 0.02% |
| Consecutive Losing Trades | 28,571 | 25,714 | 22,857 | 20,000 | 17,143 | 14,286 | 11,429 | 8,571 | 5,714 | 2,857 |